Industry-First Program at the Intersection of Digital Technology and Healthcare
By HITLAB Staff
As digital technologies define and drive a new era in patient care, Columbia Business School Executive Education has teamed up with HITLAB, a digital health innovation organization that focuses on the diffusion of technology to improve lives worldwide, to offer an industry-first program that distills how digital technologies can transform life science research, clinical development, patient experience, operations, and business models.
“Digital technologies are changing the healthcare sector at an unprecedented pace,” said Stan Kachnowski, PhD, chair of HITLAB and program faculty director. “It is a priority area for the health ecosystem at large.”
Remote patient monitoring devices, electronic health records, big data, artificial intelligence, and mobile apps that promote individual well-being are all part of the digital health industry that is projected to exceed $379.3 billion worldwide by 2024—a 25% growth rate from 2016. The first program under this partnership, Digital Health Strategy, will take place in March 2019. In addition, Columbia Business School Executive Education and HITLAB will hold an inaugural launch event on Friday, November 9, in New York City bringing together industry leaders to discuss the future of technology’s impact on delivering quality patient care.
A Partnership That Directly Addresses Digital Disruption in Healthcare
“We’re very excited about the partnership,” says Dil Sidhu, Associate Dean of Columbia Business School Executive Education. “Participants will have the opportunity to tap into Columbia Business School’s world-renowned leadership expertise and HITLAB’s preeminent know-how of the healthcare sector.”
Columbia Business School is a world-recognized leader in business education whose executive education programs have trained tens of thousands of executives both in person and on demand. And for more than two decades, HITLAB has focused on disruptive ideas and effective technologies to improve lives worldwide. Together, the organizations have the experience and insights needed to develop this unique offering.
Digital Health Strategy will give executives from the healthcare, technology, and investment industries the terms, techniques, and tools they need to transform their organizations in the digital age.
“The program stands out because of its real-world applications for executive leadership, a first in the digital health ecosystem. Participants exit the program with actionable business insights and a strategic roadmap to impact patient lives,” said Jessica Federer, former Chief Digital Officer at Bayer and program advisor.
For more information on the Digital Health Strategy program, visit the program page.
About Columbia Business School
Columbia Business School is the only world–class, Ivy League business school that delivers a learning experience where academic excellence meets with real–time exposure to the pulse of global business. Led by Dean Glenn Hubbard, the School’s transformative curriculum bridges academic theory with unparalleled exposure to real world business practice, equipping students with an entrepreneurial mindset that allows them to recognize, capture, and create opportunity in any business environment. The thought leadership of the School’s faculty and staff, combined with the accomplishments of its distinguished alumni and position in the center of global business, means that the School’s efforts have an immediate, measurable impact on the forces shaping business every day. To learn more about Columbia Business School’s position at the very center of business, please visit www.gsb.columbia.edu.
HITLAB is an innovation and teaching lab dedicated to improving the quality and accessibility of healthcare worldwide. We help leading organizations ideate, create, evaluate, and diffuse technology-based solutions to pressing healthcare challenges.
Our team of public health professionals, statisticians, clinicians, engineers, economists, strategists, designers, and anthropologists is determined to address healthcare needs across the globe. We work with a wide variety of stakeholders in both the public and private sectors to design and disseminate studies, programs, and products that improve healthcare access and delivery.